Organization
Department of Symptom Research
4 abstracts
Abstract
Patient-reported symptom interference with activity- and mood-related functioning prior to start of an early-phase oncology combination trial including immune checkpoint blockade.Org: Department of Symptom Research,
Abstract
Evidence to support ePRO-based patient care in survivorship for outpatient with advanced upper gastrointestinal cancer.Org: Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Houston, TX,
Abstract
Effect of fecal transplantation on patients’ reported outcome after immune checkpoint inhibitor colitis.Org: MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Texas MD Anderson Cancer Center, Department of Symptom Research, University of Texas at MD Anderson Cancer Center,
Abstract
Baseline symptom, health status, and health utilities in patients in early-phase clinical trials combining immune checkpoint blockade with other anticancer therapies.Org: Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Investigational Cancer Therapeutics,